Influenza Infection Risk and Predominate Exposure Route: Uncertainty Analysis

Risk Analysis

Volumn 31, Issue 10, 2011, Pages 1622-1631

  Jones, Rachael M ^a   Adida, Elodie ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

Author keywords

Exposure route; Infection risk; Influenza; Uncertainty analysis

Indexed keywords

DIFFERENT SIZES; DROPLET SPRAYS; EQUAL PROBABILITY; EXPOSURE ROUTE; GUINEA PIGS; HUMAN STUDY; INFECTION RISK; INFLUENZA; MONTE CARLO SIMULATION; ORDERS OF MAGNITUDE; RESPIRABLE AEROSOLS; RESPIRABLE PARTICLES; RESPIRATORY TRACT; UPPER RESPIRATORY TRACT; VIRUS CONCENTRATION;

COMPUTER SIMULATION; MATHEMATICAL MODELS; MONTE CARLO METHODS; PARTICLE SIZE ANALYSIS; RISKS; VIRUSES;

UNCERTAINTY ANALYSIS;

AEROSOL; INFECTIOUS DISEASE; INFECTIVITY; INFLUENZA; MONTE CARLO ANALYSIS; NUMERICAL MODEL; RESPIRATION; RISK ASSESSMENT; RODENT; UNCERTAINTY ANALYSIS; VIRUS;

ARTICLE; DISEASE TRANSMISSION; HUMAN; INFLUENZA; MONTE CARLO METHOD; PROBABILITY; RISK ASSESSMENT; UNCERTAINTY;

HUMANS; INFLUENZA, HUMAN; MARKOV CHAINS; MONTE CARLO METHOD; PROBABILITY; RISK ASSESSMENT; UNCERTAINTY;

CAVIA;

EID: 80054122749     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2011.01600.x     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention. Community Strategy for Pandemic Influenza Mitigation, 2009. Available at:, Accessed on September 15, 2009.
2. Institute of Medicine Committee on Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A. Respiratory Protection for Healthcare Workers in the Workplaces Against Novel N1H1 Influenza A. Washington, DC National Academies Press, 2009.
3. Dimitrov N, Goll S, Meyers LA, Pourbohloul B, Hupert N. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic (H1N1) influenza, 2009. PLoS Currents: Influenza, 2009; 1:RRN1127.
4. Collin N, de Radigues X, and the World Health Organization H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine, 2009; 27:5184-5186.
5. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clinic Proceedings, 2010; 85:64-76.
6. Olofsson S, Kumlin U, Dimock K, Arnberg N. Avian influenza and sialic acid receptors: More than meets the eye Lancet Infectious Diseases, 2005; 5:184-188.
7. Belser JA, Wadford DA, Xu J, Katz JM, Tumpey TM. Ocular infection of mice with influenza A (H7) viruses: A site of primary replication and spread to the respiratory tract. Journal of Virology, 2009; 83:7075-7084.
8. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Influenza virus receptors in the human airway: Avian and human flu viruses seem to target different regions of a patient's respiratory tract. Nature, 2006; 440:435-436.
9. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, Kuiken T. H5N1 virus attachment to lower respiratory tract. Science, 2006; 312:399.
10. van Riel D, Munster VJ, de Wit E, Rimmelzwaan FG, Fouchier RAM, Osterhaus ADME, Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. American Journal of Pathology, 2007; 171:1215-1223.
11. Scull MA, Gillim-Ross L, Santos C, Roberts KL, Bordonali E, Subbarao K, Barclay WS, Pickles RJ. Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathogens, 2009; 5:e1000424.
12. Nicas M, Jones RM. The relative contributions of four exposure pathways to influenza infection risk. Risk Analysis, 2009; 29:1292-1303.
13. Mubareka S, Lowen AC, Steel J, Coates AL, García-Sastre A, Palese P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. Journal of Infectious Diseases, 2009; 199:858-865.
14. Aiello AE, Murray GF, Perez V, Coulborn RM, Davis BM, Uddin M, Shay DK, Waterman SH, Monto AS. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: A randomized intervention trial. Journal of Infectious Diseases, 2010; 201:491-498.
15. Larson EL, Ferng Y, Wong-McLoughlin J, Wang S, Haber M, Morse SS. Impact of non-pharmaceutical interventions on URIs and influenza in crowded, urban households. Public Health Reports, 2010; 125:178-191.
16. Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Colavin V, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: A randomized trial. Journal of American Medical Association, 2009; 302:1865-1871.
17. Cowling BJ, Fung RO, Cheng CK, Fang VJ, Chan KH, Seto WH, et al.. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One, 2008; 3:e2102.
18. Aiello AE, Coulborn RM, Aragon TJ, Baker MG, Burrus BB, Cowling BJ, et al.. Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research. American Journal of Infection Control, 2010; 38:251-258.
19. Nicas M, Sun G. An integrated model of infection risk in a health-care environment. Risk Analysis, 2006; 26:1085-1096.
20. Jones RM. Critical review and uncertainty analysis of factors influencing influenza transmission. Risk Analysis; in press.
21. Hinds WC. Aerosol Technology: Properties, Behavior and Measurement of Airborne Particles, 2nd edition. New York John Wiley & Sons, Inc., 1999.
22. Nicas M, Nazaroff WW, Hubbard A. Toward understanding the risk of secondary airborne infection: Emission of respirable pathogens. Journal of Occupational and Environmental Hygiene, 2005; 2:143-154.
23. Haas CN, Rose JB, Gerba CP. Quantitative Microbial Risk Assessment. New York John Wiley & Sons, Inc., 1999.
24. Alford RH. An attempt at protection of man against virulent influenza using nasal instillation of inactivated virus. Annals of Internal Medicine, 1965; 62:1312-1314.
25. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proceedings of the Society for Experimental Biology and Medicine, 1966; 122:800-804.
26. Lowen AC, Mubareka S, Tumpey TM, García-Sastre A, Palese P. The guinea pig as a transmission model for human influenza viruses. Proceedings of the National Academy of Sciences USA, 2006; 103:9988-9992.
27. Harper GJ. Airborne micro-organisms: Survival tests with four viruses. Journal of Hygiene (London), 1961; 59:479-486.
28. Hemmes JH, Winkler KC, Kool SM. Virus survival as a seasonal factor in influenza and poliomyelitis. Nature, 1960; 188:430-431.
29. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour Jr HH. Survival of influenza viruses on environmental surfaces. Journal of Infectious Diseases, 1982; 146:47-51.
30. Treanor JJ, Hayden FG, Vrooman PS, Barabarsh R, Bettis R, Riff D, Singh S, Knersley N, Ward P, Mills RG, for the US Oral Neuraminidase Study Group. Efficacy and safety of the oral neuraminidase inhibitor Oseltamivir in treating acute influenza. Journal of the American Medical Association, 2000; 283:1016-1024.
31. Lee N, Chan PKS, Hui DSC, Rainer TH, Wong E, Choi KW, Lui GCY, Wong BCK, Wong RYK, Lam WY, Chu IMT, Lai RWM, Cockram CS, Sung JJY. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. Journal of Infectious Diseases, 2009; 200:492-500.
32. Loudon RG, Brown LC. Cough frequency in patients with respiratory disease. American Review of Respiratory Disease, 1967; 96:1137-1143.
33. Paul IM, Wai K, Jewell SJ, Schaffer ML, Varadan VV. Evaluation of a new self-contained, ambulatory, objective cough monitor. Cough, 2006; 2:7. doi.
34. Kuhn JJ, Hendley JO, Adams KF, Clark JW, Gwaltney Jr. JM. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, 1982; 82:713-718.
35. Chao CYH, Wan MP, Morawska L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Li Y, Xie X, Katoschevki D. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. Aerosol Science, 2009; 40:122-133.
36. Nicas M, Best D. A study quantifying the hand-to-face contact rate and its potential application to predicting respiratory tract infection. Journal of Occupational and Environmental Hygiene, 2008; 5:347-352.
37. Thomas Y, Vogel G, Wunderli W, Suter P, Witschi M, Koch D, Tapparel C, Kaiser L. Survival of influenza virus on banknotes. Applied and Environmental Microbiology, 2008; 74:3002-3007.
38. Xue J, Zartarian VG, Oezkaynak H, Dang W, Glen G, Smith L, Stallings C. A probabilistic arsenic exposure assessment for children who contact chromated copper arsenate (CCA)-treated playsets and decks, part 2: Sensitivity and uncertainty analyses. Risk Analysis, 2006; 26:533-541.
39. Julian TR, Canales RA, Leckie JO, Boehm AB. A model of exposure to rotavirus from nondietary ingestion iterated by simulated intermittent contacts. Risk Analysis, 2009; 25:617-631.
40. Stelzer-Braid S, Oliver BG, Blazey AJ, Argent E, Newsome TP, Ralwingson WD, Tovey ER. Exhalation of respiratory viruses by breathing, coughing and talking. Journal of Medical Virology, 2009; 81:1674-1679.
41. Fabian P, McDevitt JJ, DeHaan WH, Fung RPO, Cowling BJ, Chan KH, Leung GM, Milton DK. Influenza virus in human exhaled breath: An observational study. PLoS One, 2008; 3:e2691.
42. Cao B, Li XW, Shu Y, Jiang N, Chen S, Xu X, Wang C, and for the National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of the 2009 pandemic influenza A (H1N1) virus infection in China. New England Journal of Medicine, 2009; 361:2507-2517.
43. Al Kuwaitir TS, Al Abdulkarim AS, Abba AA, Yousef AM, El-Din MA, Rahman KT, Ali MA, Mohamed ME, Arnous NE. H1N1 influenza A: Preliminary evaluation in hospitalized patients in a secondary care facility in Saudi Arabia. Saudi Medical Journal, 2009; 30:1532-1536.
44. Loudon RG, Roberts RM. Droplet expulsion from the respiratory tract. American Review of Respiratory Disease, 196; 95:435-442.
45. Fennelly KP, Martyny JW, Fulton KE, Orme IM, Cave DM, Heifets LB. Cough-generated aerosols ofMycobacterium tuberculosis: A new method to study infectiousness. American Journal of Respiratory and Critical Care Medicine, 2004; 169:604-609.
46. Wainwright CE, France MW, O'Rourke P, Anuj S, Kidd TJ, Nissen MD, Sloots TP, Coulter C, Ristovski Z, Hargreaves M, Rose BR, Harbour C, Bell SC, Fennelly KP. Cough-generated aerosols ofPsuedomonas aeruginosaand other Gram-negative bacteria from patients with cystic fibrosis. Thorax, 2009; 64:926-931.
47. Schwarz K, Biller H, Windt H, Koch W, Hohlfeld JM. Characterization of exhaled particles from the healthy human lung: A systematic analysis in relation to pulmonary function variables. Journal of Aerosol Medicine Pulmonary Drug Delivery, 2010; 23:371-379.
48. Johnson GR, Morawska L. The mechanism of breath aerosol formation. Journal of Aerosol Medicine Pulmonary Drug Delivery, 2009; 22:229-237.
49. Morawska L. Droplet fate in indoor environments, or can we prevent the spread of infection. Indoor Air, 2006; 16:335-347.
50. Lindsley WG, Blachere FM, Thewlis RE, Vishnu A, Davis KA, Cao G, Palmer JE, Clark KE, Fisher MA, Khakoo R, Beezhold DH. Measurements of airborne influenza virus in aerosol particles from human coughs. PLOSone, 2010; 5:e15100.
51. Lowen AC, Mubareka S, Steel J, Palese P. Influenza virus transmission is dependent upon relative humidity and temperature. PLoS Pathology, 2007; 3:e151.
52. Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30°C) blocks aerosol but not contact transmission of influenza virus. Journal of Virology, 2008; 82:5650-5652.
53. Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PDR, Mastorakos T, Birch C. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clinical Infectious Diseases, 2009; 48:285-291.
54. Wein LM, Atkinson MP. Assessing infection control measures for pandemic influenza. Risk Analysis, 2009; 29:949-962.
55. Atkinson MP, Wein LM. Quantifying the routes of transmission for pandemic influenza. Bulletin of Mathematical Biology, 2008; 70:820-867.